Exact Sciences Corporation (EXAS)

NasdaqCM • Currently up 46.14 (+79.95%) in today's trading session

Track congressional stock trades in Exact Sciences Corporation (EXAS). Analyze trading activity from Nancy Pelosi and other members of Congress with real-time financial disclosure data, interactive price charts, and detailed transaction records.

Exact Sciences Corporation is currently trading at $103.85, positioned at 100% of its 52-week range ($38.81 – $103.92). View which politicians have recently bought or sold EXAS and how their trades align with market movements.

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio in real-time with just one click on eToro.

Free asset at sign up • Eligible regions only
Copy PortfolioClaim Free Asset
Live portfolio tracking
Automatic rebalancing

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Not available in the US.

Past Performance is not an indication of future results.

*Free asset promotion available at sign up in eligible regions only. Terms and conditions apply.

Current Price
$103.85
24h Change
+46.14 (+79.95%)
52 Week Range
$38.81—$103.92
View on NASDAQ

Exact Sciences Corporation Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for EXAS

Select to highlight on chart
8 transactions
Compliance: 100%
Kevin Hern02 Jan 202411 Feb 2024SaleStock$1,001 - $15,000N/A (Sale Transaction)
Kevin Hern31 Jan 202314 Feb 2023SaleStock$1,001 - $15,000N/A (Sale Transaction)
Josh Gottheimer20 Jan 202317 Feb 2023PurchaseStock$1,001 - $15,000N/A (Price Data Unavailable)
Kevin Hern19 Dec 202213 Jan 2023SaleStock$50,001 - $100,000N/A (Sale Transaction)
Kevin Hern16 May 202214 Jun 2022SaleStock$1,001 - $15,000N/A (Sale Transaction)
Kevin Hern20 May 202115 Jun 2021PurchaseStock$1,001 - $15,000N/A (Price Data Unavailable)
Kevin Hern20 May 202115 Jun 2021PurchaseStock$50,001 - $100,000N/A (Price Data Unavailable)
Kevin Hern27 Jul 202015 Aug 2020PurchaseStock$1,001 - $15,000N/A (Price Data Unavailable)

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$19.82B

Volume

2.71M

Beta

1.44

P/E Ratio

-94.41

Fundamentals

EPS

$-1.10

Div. Yield

—

Open

$103.69

Day Range

$103.60 — $103.92

Company Information

Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ · USD
Country
US
CEO
Kevin T. Conroy
IPO Date
2001-02-01
Website
www.exactsciences.com

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated...

Earnings

Next Report

Q1 2026

7 May

EPS Est.

$0.13

Rev. Est.

$835.6M

Days Until

51

Recent Quarters

Q4 202513 Feb
EPS$-0.21
Miss 94.6%
Q3 20253 Nov
EPS$0.24
Beat 492.0%
Q2 20256 Aug
EPS$0.22
Beat 1200.0%
Q1 20251 May
EPS$-0.21
Beat 43.2%
Q4 202419 Feb
EPS$-0.06
Beat 79.3%
Q3 20245 Nov
EPS$-0.21
Miss 7.2%
Q2 202431 Jul
EPS$-0.09
Beat 75.7%
Q1 20248 May
EPS$-0.50
Miss 5.3%
Q4 202321 Feb
EPS$-0.27
Beat 49.1%
Q3 20231 Nov
EPS$0.00
Beat 100.9%
Q2 20231 Aug
EPS$-0.45
Beat 10.0%
Q1 20239 May
EPS$-0.42
Beat 46.8%
Q4 202221 Feb
EPS$-0.72
Beat 20.0%
Q3 20223 Nov
EPS$-0.84
Beat 23.6%
Q2 20222 Aug
EPS$-0.94
Beat 12.2%
Q1 202226 Apr
EPS$-1.04
Beat 7.1%
Q4 202122 Feb
EPS$-1.28
Miss 40.7%
Q3 20212 Nov
EPS$-0.97
Miss 9.0%
Q2 202128 Jul
EPS$-1.03
Miss 43.1%
Q1 20214 May
EPS$-0.18
Beat 82.7%
Q4 202016 Feb
EPS$-0.09
Beat 52.6%
Q3 202027 Oct
EPS$-0.36
Beat 29.4%
Q2 202030 Jul
EPS$-0.58
Beat 6.5%
Q1 20206 May
EPS$-0.60
Miss 5.3%
Q4 201911 Feb
EPS$-0.37
Beat 0.0%
Q3 201929 Oct
EPS$-0.31
Beat 24.4%
Q2 201929 Jul
EPS$-0.30
Beat 46.4%
Q1 201930 Apr
EPS$-0.66
Miss 3.1%
Q4 201821 Feb
EPS$-0.44
Beat 12.0%
Q3 201830 Oct
EPS$-0.30
Beat 28.6%
Q2 20181 Aug
EPS$-0.30
Beat 9.1%
Q1 201826 Apr
EPS$-0.33
Beat 15.4%
Q4 201722 Feb
EPS$-0.18
Beat 33.3%
Q3 201730 Oct
EPS$-0.23
Beat 23.3%
Q2 201725 Jul
EPS$-0.27
Beat 27.0%
Q1 201727 Apr
EPS$-0.32
Beat 21.9%
Q4 201621 Feb
EPS$-0.34
Beat 12.8%
Q3 201626 Oct
EPS$-0.36
Beat 16.3%
Q2 201626 Jul
EPS$-0.46
Beat 16.4%
Q1 20163 May
EPS$-0.49
Beat 9.3%
Q4 201524 Feb
EPS$-0.41
Beat 14.6%
Q3 201529 Oct
EPS$-0.45
Miss 2.3%
Q2 201520 Jul
EPS$-0.44
Beat 2.2%
Q1 20154 May
EPS$-0.40
Beat 0.0%
Q4 201424 Feb
EPS$-0.38
Beat 2.6%
Q3 201427 Oct
EPS$-0.39
Miss 14.7%
Q2 201422 Jul
EPS$-0.24
Beat 4.0%
Q1 20141 May
EPS$-0.23
Miss 21.1%
Q4 201320 Feb
EPS$-0.17
Beat 10.5%
Q3 201329 Oct
EPS$-0.16
Beat 11.1%
Q2 201323 Jul
EPS$-0.19
Miss 5.6%
Q1 20131 May
EPS$-0.17
Beat 15.0%
Q4 201220 Feb
EPS$-0.22
Miss 29.4%
Q3 201230 Oct
EPS$-0.21
Beat 0.0%
Q2 201225 Jul
EPS$-0.26
Miss 36.8%
Q1 20121 May
EPS$-0.19
Miss 5.6%
Q4 201123 Feb
EPS$-0.18
Miss 5.9%
Q3 20113 Nov
EPS$-0.15
Beat 0.0%
Q2 20112 Aug
EPS$-0.13
Miss 30.0%
Q1 20113 May
EPS$-0.08
Beat 11.1%
Q4 201015 Feb
EPS$-0.08
Beat 0.0%
Q3 201027 Oct
EPS$-0.08
Miss 14.3%
Q2 201028 Jul
EPS$-0.06
Beat 0.0%
Q1 20106 May
EPS$-0.06
Miss 20.0%
Q4 200912 Mar
EPS$-0.05
Q4 200916 Feb
EPS$-0.05
Beat 0.0%
Q2 200913 Aug
EPS$-0.08
Q1 200915 May
EPS$-0.13
Q4 200831 Mar
EPS$-0.08
Q3 20087 Nov
EPS$-0.11
Q2 20088 Aug
EPS$-0.08
Q1 20089 May
EPS$-0.09
Q4 200717 Mar
EPS$-0.15
Q3 20076 Nov
EPS$-0.16
Q2 20078 Aug
EPS$-0.07
Q1 20078 May
EPS$-0.07
Q4 200615 Mar
EPS$-0.09
Q3 20069 Nov
EPS$-0.12
Q2 200624 Jul
EPS$-0.12
Beat 14.3%
Q1 200624 Apr
EPS$-0.14
Miss 7.7%
Q4 200523 Jan
EPS$-0.10
Beat 23.1%
Q3 200524 Oct
EPS$-0.13
Beat 0.0%
Q2 200525 Jul
EPS$-0.15
Beat 0.0%
Q1 200525 Apr
EPS$-0.17
Beat 0.0%
Q4 200424 Jan
EPS$-0.17
Beat 5.6%
Q3 200425 Oct
EPS$-0.17
Beat 10.5%
Q2 200426 Jul
EPS$-0.16
Beat 23.8%
Q1 200426 Apr
EPS$-0.23
Beat 4.2%
Q4 200326 Jan
EPS$-0.29
Miss 422.2%
Q3 200327 Oct
EPS$-0.34
Beat 5.6%
Q2 200321 Jul
EPS$-0.40
Beat 2.4%
Q1 200328 Apr
EPS$-0.40
Miss 2.6%
Q4 200227 Jan
EPS$-0.36
Miss 2.9%
Q3 200221 Oct
EPS$-0.37
Miss 8.8%
Q2 200222 Jul
EPS$-0.40
Miss 2.6%
Q1 200222 Apr
EPS$-0.39
Miss 8.3%
Q4 200130 Jan
EPS$-0.32
Beat 13.5%
Q3 200122 Oct
EPS$-0.27
Beat 10.0%
Q2 200123 Jul
EPS$-0.26
Beat 0.0%
Q1 200114 May
EPS$-0.44
Q1 200125 Apr
EPS$-0.27
Miss 3.9%

2 politicians traded within 30 days

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

LLY

Eli Lilly and Company

47
$989.12+4.04 (+0.41%)
Healthcare
Held by same politician
Same sector: Healthcare
1 politician
View Stock

NVDA

NVIDIA Corporation

20
$183.22+2.97 (+1.65%)
Technology
Held by same politician
Significant holdings value
1 politician
View Stock

PTSNX

PIMCO Short Term I-3

17
$9.680.00 (0.00%)
Held by same politician
1 politician
View Stock
Pelosi TrackerJoin our Discord
PoliticiansPortfoliosPricingLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. This website is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office, or her representatives. Any use of her name is solely for the purpose of discussing publicly available information.The information provided on this website is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.